Weill Cornell Medicine Multiple Sclerosis Center

You are here

News & Updates

High Dose Biotin again showed benefit in progressive multiple sclerosis in a small study in France

High Dose Biotin again showed benefit in progressive multiple sclerosis in a small study in France

Jonathan Ciron, MD from Toulouse France presented their clinical findings in first 91 patients with primary or secondary progressive multiple sclerosis followed for one year on 300 mg day.They looked at EDSS, 25 foot timed walk, 9 hole peg test , number of relapses and gad lesions on MRI.Mean age was 59 yr, 61% were females. Mean EDSS was 5.9. An EDSS of 6 means needing cane to walk.After 1 year, 23% of patients improved on EDSS and 23% improved on 25 foot timed walk.This high dose vitamin...
Summary of a recent publication in Brain journal on our study looking at MS lesion pathology

Summary of a recent publication in Brain journal on our study looking at MS lesion pathology

Dr. Ulrike Kaunzner was the first author on a paper that has been published under the leadership of Dr. Susan Gauthier in the journal “Brain”, that combined two imaging techniques to shed better light on the presence of chronic active lesions in MS patients.
Source of toxin that has been postulated to cause MS lesions may be food

Source of toxin that has been postulated to cause MS lesions may be food

The bacterial epsilon toxin has been proposed as a possible cause of new MS lesion formation.  How people may be exposed to this toxin and the bacteria that produce it are unknown.  To try and determine how humans may become colonized or infected with these types of bacteria, 216 food samples from New York City groceries were tested.  Of the 216 samples, three were positive for the epsilon toxin-producing bacteria, suggesting that humans may be exposed to the bacteria by consuming contaminated...

Weill Cornell Medicine Multiple Sclerosis Center 1305 York Ave., Second Floor New York, NY 10021